+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

North America Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

  • PDF Icon

    Report

  • 164 Pages
  • April 2026
  • Region: North America
  • GlobalData
  • ID: 6077609
The “North America Neuromodulation Devices Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Implantable Neuromodulation Devices, Minimally Invasive Neuromodulation Devices and Non-Invasive Neuromodulation Devices

The North America Neuromodulation Devices Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2025 company share data for Neuromodulation Devices Market.
  • Global corporate-level profiles of key companies operating within the North America Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Neuromodulation Devices is segmented as follows:

  • Implantable Neuromodulation Devices
  • Minimally Invasive Neuromodulation Devices
  • Non-Invasive Neuromodulation Devices

Reasons to Buy

The North America Neuromodulation Devices Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Rhythm Management Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Rhythm Management Devices Market, Russia
2.1 Cardiac Rhythm Management Devices Market, Russia, Revenue ($m), 2024-2036
2.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Russia, Revenue ($m), by Segment, 2024-2036
2.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Russia, Revenue ($m), by Segment, 2024-2036
2.1.3 Pacemakers Market, Russia, Revenue ($m), by Segment, 2024-2036
2.2 Cardiac Rhythm Management Devices Market, Russia, Volume (Units), 2024-2036
2.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Russia, Volume (Units), by Segment, 2024-2036
2.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Russia, Volume (Units), by Segment, 2024-2036
2.2.3 Pacemakers Market, Russia, Volume (Units), by Segment, 2024-2036
2.3 Cardiac Rhythm Management Devices Market, Russia, Average Price ($), 2024-2036
2.4 Cardiac Rhythm Management Devices Market, Russia, Company Share by Revenue ($m), 2025
3 Cardiac Rhythm Management Devices Market Pipeline Products
3.1 Cardiac Rhythm Management Devices Market Pipeline Products
3.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
3.3 Cardiac Rhythm Management Devices - Pipeline Products by Segment
3.4 Cardiac Rhythm Management Devices - Pipeline Products by Territory
3.5 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
3.6 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Russia, Cardiac Rhythm Management Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Biotronik SE & Co KG
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Boston Scientific Corp
4.4.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms
5.2 Product News
5.2.1 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Resynchronisation Therapy (CRT) Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 3: Implantable Cardioverter Defibrillators (ICD) Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 4: Pacemakers Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 5: Cardiac Rhythm Management Devices Market, Russia, Volume (Units), 2024-2036
Table 6: Cardiac Resynchronisation Therapy (CRT) Market, Russia, Volume (Units), 2024-2036
Table 7: Implantable Cardioverter Defibrillators (ICD) Market, Russia, Volume (Units), 2024-2036
Table 8: Pacemakers Market, Russia, Volume (Units), 2024-2036
Table 9: Cardiac Rhythm Management Devices Market, Russia, Average Price ($), 2024-2036
Table 10: Cardiac Rhythm Management Devices Market, Russia, Company Share by Revenue ($m), USD Constant, 2025
Table 11: Cardiac Rhythm Management Devices Market Pipeline Products
Table 12: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 13: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
Table 14: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table 15: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Table 16: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Table 17: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Table 18: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 4: Pacemakers Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 5: Cardiac Rhythm Management Devices Market, Russia, Volume (Units), 2024-2036
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, Russia, Volume (Units), 2024-2036
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, Russia, Volume (Units), 2024-2036
Figure 8: Pacemakers Market, Russia, Volume (Units), 2024-2036
Figure 9: Cardiac Rhythm Management Devices Market, Russia, Company Share (%), 2025
Figure 10: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Figure 11: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Figure 12: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Figure 13: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Figure 14: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • LivaNova Plc
  • Nevro Corp
  • Axonics Inc
  • NeuroPace Inc